Brandtree

Who owns Cetaphil?

Cetaphil is owned by Galderma (Switzerland, SIX: GALD).[1]

This ownership is reported in official statements but has not yet been matched to a regulatory filing.

Evidence: Galderma Annual Report 2025, Galderma Group AG, 4 March 2026. Last checked .

Key facts

Current owner
Galderma Group AG reported
Owner HQ
🇨🇭 Switzerland, Zug
Origin
🇺🇸 United States
Founded
1947
Category
Personal care & beauty › Skin care › Dermocosmetics & clinical skin care
Parent ticker
SIX: GALD
Last verified
· 1 sources

About Cetaphil

Cetaphil is a sensitive-skin skincare brand that Galderma's 2025 annual report says was launched in 1947 with its first product, Cetaphil Cleansing Lotion, now sold as Cetaphil Gentle Skin Cleanser. It is available in more than 70 countries and offers cleansers, moisturizers, baby products and solutions for sensitive skin, and in 2025 added the Skin Activator Hydrating and Firming line and a Nourishing Oil to Foam Cleanser.

Ownership timeline of Cetaphil

Owners of Cetaphil over 1947 to 2026 Galderma start not recorded–present Galderma (start not recorded) 19501960197019801990200020102020
  1. Current owner Galderma [1] reported

Where Cetaphil sits in Galderma

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Cetaphil sits in Galderma Tree of 2 brands under Galderma. Galderma Cetaphil Alastin

Open the full Galderma ownership tree →

See the full Galderma brand portfolio (2) →

Other brands owned by Galderma

Galderma controls 2 brands on Brandtree, 2 of them in personal care & beauty.

Also in personal care & beauty

All Galderma brands →

Other brands in dermocosmetics & clinical skin care, and who owns them

The 41 brands in dermocosmetics & clinical skin care on Brandtree belong to 21 owners. The largest is Ego Pharmaceuticals, with 9; Galderma has 2.

BrandOwnerOwner based in
DermAid Ego Pharmaceuticals 🇦🇺 Australia
Biretix Cantabria Labs 🇪🇸 Spain
CeraVe L'Oréal 🇫🇷 France
A-Derma Pierre Fabre 🇫🇷 France
Dermalogica Unilever 🇬🇧 United Kingdom
Minon Daiichi Sankyo Healthcare 🇯🇵 Japan
A-Solution Aekyung 🇰🇷 South Korea
Eucerin Beiersdorf 🇩🇪 Germany

Every brand in dermocosmetics & clinical skin care and its owner →

About the owner: Galderma

Galderma is a publicly listed company headquartered in Zug, Switzerland. Brandtree records 2 brands under its control, and it is listed as SIX: GALD.

Galderma Group AG is a Swiss dermatology company, listed on the SIX Swiss Exchange since 2024, that describes itself as a pure-play dermatology category leader. It sells injectable aesthetics (Restylane, Sculptra, Dysport), prescription therapeutic dermatology (Nemluvio, Soolantra, Epiduo) and consumer skincare. Only the consumer skincare brands are recorded here; the injectables and prescription medicines have no matching category on this site.

Galderma: full profile, brands and acquisition history →

🇺🇸 Cetaphil and other American brands

Brandtree records a controlling owner for 2,399 brands that began in the United States. 461 of them (19%) are now controlled by a company headquartered in another country, Cetaphil among them.

All American brands and who owns them →

Frequently asked questions

Who is the parent company of Cetaphil?

The parent company of Cetaphil is Galderma, a publicly listed company headquartered in Switzerland.

Is Cetaphil American or Swiss?

Cetaphil originated in the United States in 1947, but it is owned today by Galderma, which is headquartered in Switzerland. So Cetaphil is an American-origin brand under Swiss ownership.

Is Cetaphil still owned by Galderma?

Yes. As of 3 October 2026, Cetaphil is still owned by Galderma. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Galderma Annual Report 2025 — Galderma Group AG, Annual report, published 4 March 2026; retrieved 3 October 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.